Derivation of Tumor Specific Hybridomas

Summary

This is a non-randomized, open-label study in patients with newly diagnosed glioblastoma to determine the ability to generate human hybridomas from lymph nodes draining an autologous tumor vaccine injection and demonstrate that the hybridomas secrete glioblastoma-specific antibodies.

Timeline

Start

2014-01

Primary completion

2015-05-06

Completion

2015-05-06

Drugs

Indications